Vaniprevir (BioDeep_00000771869)
代谢物信息卡片
化学式: C38H55N5O9S (757.37203)
中文名称: Vaniprevir
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCC1CC1(C(=O)NS(=O)(=O)C2CC2)NC(=O)C3CC4CN3C(=O)C(NC(=O)OCC(CCCCC5=C6CN(CC6=CC=C5)C(=O)O4)(C)C)C(C)(C)C
InChI: InChI=1S/C38H55N5O9S/c1-7-25-18-38(25,33(46)41-53(49,50)27-14-15-27)40-31(44)29-17-26-20-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)16-9-8-11-23-12-10-13-24-19-42(21-28(23)24)35(48)52-26/h10,12-13,25-27,29-30H,7-9,11,14-22H2,1-6H3,(H,39,47)(H,40,44)(H,41,46)/t25-,26-,29+,30-,38-/m1/s1
描述信息
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
C254 - Anti-Infective Agent > C281 - Antiviral Agent
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
同义名列表
1 个代谢物同义名
数据库引用编号
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Khushboo Bafna, Kris White, Balasubramanian Harish, Romel Rosales, Theresa A Ramelot, Thomas B Acton, Elena Moreno, Thomas Kehrer, Lisa Miorin, Catherine A Royer, Adolfo García-Sastre, Robert M Krug, Gaetano T Montelione. Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.
Cell reports.
2021 05; 35(7):109133. doi:
10.1016/j.celrep.2021.109133. [PMID: 33984267] - L Caro, J de Hoon, M Depré, C Cilissen, J Miller, W Gao, D Panebianco, Z Guo, S L Troemel, M S Anderson, N Uemura, J Butterton, J Wagner, D H Wright. Single-Dose and Multiple-Dose Pharmacokinetics of Vaniprevir in Healthy Men.
Clinical and translational science.
2017 Nov; 10(6):480-486. doi:
10.1111/cts.12482. [PMID: 28796416] - Takuro Uchida, Nobuhiko Hiraga, Michio Imamura, Satoshi Yoshimi, Hiromi Kan, Eisuke Miyaki, Masataka Tsuge, Hiromi Abe, C Nelson Hayes, Hiroshi Aikata, Yuji Ishida, Chise Tateno, Joan D Ellis, Kazuaki Chayama. Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice.
Virus research.
2016 Feb; 213(?):62-68. doi:
10.1016/j.virusres.2015.11.010. [PMID: 26569595] - D Hamish Wright, Luzelena Caro, Michael Cerra, Paul Panorchan, Lihong Du, Melanie Anderson, Andrej Potthoff, Robert B Nachbar, John Wagner, Michael P Manns, Andrew H Talal. Liver-to-plasma vaniprevir (MK-7009) concentration ratios in HCV-infected patients.
Antiviral therapy.
2015; 20(8):843-8. doi:
10.3851/imp2958. [PMID: 25849338] - Michael P Manns, Edward Gane, Maribel Rodriguez-Torres, Albrecht Stoehr, Chau-Ting Yeh, Patrick Marcellin, Richard T Wiedmann, Peggy M Hwang, Luzelena Caro, Richard J O Barnard, Andrew W Lee. Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: a randomized phase II study.
Hepatology (Baltimore, Md.).
2012 Sep; 56(3):884-93. doi:
10.1002/hep.25743. [PMID: 22473713] - John A McCauley, Charles J McIntyre, Michael T Rudd, Kevin T Nguyen, Joseph J Romano, John W Butcher, Kevin F Gilbert, Kimberly J Bush, M Katharine Holloway, John Swestock, Bang-Lin Wan, Steven S Carroll, Jillian M DiMuzio, Donald J Graham, Steven W Ludmerer, Shi-Shan Mao, Mark W Stahlhut, Christine M Fandozzi, Nicole Trainor, David B Olsen, Joseph P Vacca, Nigel J Liverton. Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor.
Journal of medicinal chemistry.
2010 Mar; 53(6):2443-63. doi:
10.1021/jm9015526. [PMID: 20163176] - Nigel J Liverton, Steven S Carroll, Jillian Dimuzio, Christine Fandozzi, Donald J Graham, Daria Hazuda, M Katherine Holloway, Steven W Ludmerer, John A McCauley, Charles J McIntyre, David B Olsen, Michael T Rudd, Mark Stahlhut, Joseph P Vacca. MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease.
Antimicrobial agents and chemotherapy.
2010 Jan; 54(1):305-11. doi:
10.1128/aac.00677-09. [PMID: 19841155] - M D G Anderson, S A Breidinger, E J Woolf. Effect of disease state on ionization during bioanalysis of MK-7009, a selective HCV NS3/NS4 protease inhibitor, in human plasma and human Tween-treated urine by high-performance liquid chromatography with tandem mass spectrometric detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2009 Apr; 877(11-12):1047-56. doi:
10.1016/j.jchromb.2009.02.069. [PMID: 19328051]